Discussion
anxiety, GDM, Diabetes, depression, diabetes [, diabetes
GDM, DIABETES, CARBOHYDRATE INTOLERANCE, DIABETES
We found no significant differences in the proportion of women with anxiety, vulnerability for depression and poor mental HRQoL among women in the two glycaemic target groups. The mean scores for the measures of anxiety, depression and HRQoL were also not different between the two groups.Currently recommended glycaemic treatment targets for the management of GDM differ across countries and professional associations. In the United States, the American Diabetes Association recommends fasting plasma glucose < 95 mg/dL (< 5.3 mmol/L); 1-h postprandial < 140 mg/dL (< 7.8 mmol/L); and 2-h postprandial < 120 mg/dL (< 6.7 mmol/L) [Studies assessing the association between glycaemic control and mental well-being in the general diabetes population have produced varying results. While some studies have showed good mental well-being is associated with intense glycaemic control [In women with GDM, evidence of a relationship between glycaemic control with psychological well-being is limited. In the TARGET Trial, women who were allocated to the tighter treatment target group had higher rates of use of pharmacological agents compared to those managed with the less-tight targets [The improvement in maternal mental health outcomes found in the Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) trial has been suggested to represent the beneficial effect of increased care that women with GDM may receive when treatment is offered [Some studies have suggested that the link between GDM and poor mental health outcomes, especially depression, may be bidirectional i.e., depression may also precede GDM [Additionally, some studies have suggested depression is associated with poor perceived glycaemic control in the general diabetes population [The incidence of depression and anxiety were similar between the two treatment groups at baseline, 36 weeks’ gestation, and 6 months postpartum. However, the incidence of depression and anxiety in both groups decreased at 36 weeks’ gestation compared to baseline. This result differs from some previous studies which reported a similar incidence of poor psychological outcome in the second and third trimesters in women with diabetes [